IFM Investors Pty Ltd Has $2.29 Million Position in Universal Health Services, Inc. (NYSE:UHS)

IFM Investors Pty Ltd increased its stake in Universal Health Services, Inc. (NYSE:UHS - Free Report) by 15.0% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 12,166 shares of the health services provider's stock after purchasing an additional 1,584 shares during the quarter. IFM Investors Pty Ltd's holdings in Universal Health Services were worth $2,286,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in UHS. D. E. Shaw & Co. Inc. lifted its stake in shares of Universal Health Services by 99.2% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 12,450 shares of the health services provider's stock worth $2,234,000 after buying an additional 6,200 shares during the last quarter. Smartleaf Asset Management LLC lifted its position in Universal Health Services by 30.7% during the 4th quarter. Smartleaf Asset Management LLC now owns 455 shares of the health services provider's stock worth $81,000 after acquiring an additional 107 shares during the last quarter. Cetera Investment Advisers lifted its position in Universal Health Services by 30.6% during the 4th quarter. Cetera Investment Advisers now owns 12,858 shares of the health services provider's stock worth $2,307,000 after acquiring an additional 3,011 shares during the last quarter. SG Americas Securities LLC acquired a new position in Universal Health Services during the 1st quarter worth $1,141,000. Finally, CX Institutional acquired a new position in Universal Health Services during the 1st quarter worth $74,000. 86.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on UHS shares. Guggenheim started coverage on Universal Health Services in a research report on Wednesday, April 9th. They set a "buy" rating and a $208.00 price objective for the company. Baird R W lowered Universal Health Services from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Wells Fargo & Company cut their target price on shares of Universal Health Services from $230.00 to $225.00 and set an "overweight" rating for the company in a research note on Monday, March 10th. Morgan Stanley initiated coverage on shares of Universal Health Services in a research note on Wednesday, March 26th. They set an "equal weight" rating and a $200.00 target price for the company. Finally, Stephens upgraded shares of Universal Health Services to a "hold" rating in a research note on Monday, June 2nd. Nine analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average price target of $224.77.

Universal Health Services Stock Performance

NYSE:UHS opened at $181.26 on Tuesday. Universal Health Services, Inc. has a 12-month low of $153.99 and a 12-month high of $243.25. The company has a quick ratio of 1.23, a current ratio of 1.32 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $11.78 billion, a PE ratio of 10.17, a price-to-earnings-growth ratio of 0.75 and a beta of 1.28. The firm has a 50-day moving average price of $183.30 and a 200 day moving average price of $181.54.

Universal Health Services (NYSE:UHS - Get Free Report) last issued its earnings results on Monday, April 28th. The health services provider reported $4.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.36 by $0.48. Universal Health Services had a return on equity of 17.79% and a net margin of 7.44%. The business had revenue of $4.10 billion during the quarter, compared to analysts' expectations of $4.16 billion. During the same period in the prior year, the firm posted $3.70 EPS. Universal Health Services's quarterly revenue was up 6.7% compared to the same quarter last year. Research analysts anticipate that Universal Health Services, Inc. will post 15.92 earnings per share for the current fiscal year.

Universal Health Services Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 16th. Shareholders of record on Monday, June 2nd were paid a dividend of $0.20 per share. The ex-dividend date was Monday, June 2nd. This represents a $0.80 annualized dividend and a yield of 0.44%. Universal Health Services's dividend payout ratio is currently 4.49%.

Insider Transactions at Universal Health Services

In related news, Director Maria Ruderman Singer sold 1,097 shares of the stock in a transaction dated Wednesday, May 14th. The shares were sold at an average price of $191.48, for a total transaction of $210,053.56. Following the completion of the sale, the director owned 7,884 shares in the company, valued at $1,509,628.32. This trade represents a 12.21% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 16.40% of the stock is owned by corporate insiders.

About Universal Health Services

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.